Related Experiment Video
Updated: Aug 14, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Risk factors for congestive heart failure after aortic valve replacement with a Carpentier-Edwards pericardial
Wilhelm P Mistiaen1, Philip Van Cauwelaert, Philip Muylaert
1University of Antwerp, Antwerp, Belgium. wihelm.mistiaen@ua.ac.be
Insights
Congestive heart failure (CHF) after aortic valve replacement (AVR) can be reduced by addressing preoperative conduction defects and atrial fibrillation (AF). Minimizing cross-clamp time and prompt surgery are also key to reducing CHF risk post-AVR.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Research
Background:
- Congestive heart failure (CHF) is a significant cause of morbidity following aortic valve replacement (AVR).
- Identifying preoperative risk factors for CHF is crucial for improving patient outcomes after AVR.
Purpose of the Study:
- To identify preoperative risk factors associated with the development of congestive heart failure (CHF) after aortic valve replacement (AVR).
Main Methods:
- Retrospective analysis of 500 patients undergoing AVR with a Carpentier-Edwards pericardial valve.
- Investigation of 15 potential risk factors using univariate and multivariate statistical analyses.
- Assessment of CHF development during hospital stay and long-term follow-up.
Main Results:
- During hospitalization, urgent operation, preoperative atrial fibrillation (AF), and NYHA functional class IV were significant risk factors for CHF.
- Long-term follow-up revealed that smaller valve size (<19 mm), preoperative conduction defects, postoperative AF, longer cross-clamp time (>75 min), NYHA class IV, coronary artery disease (CAD), and additional coronary artery bypass grafting (CABG) were significant.
- Multivariate analysis identified preoperative conduction defects, postoperative AF, and CAD as independent risk factors for long-term CHF.
Conclusions:
- Morbidity from CHF after AVR can be minimized by effectively treating atrial fibrillation (AF) and conduction defects.
- Preoperative factors like patient age, valve size, and cross-clamp time were not independent predictors of CHF.
- Optimizing surgical timing, minimizing cross-clamp duration, and managing AF and conduction defects are recommended to reduce CHF post-AVR.
Background And Aim Of The Study:
Congestive heart failure (CHF) after aortic valve replacement (AVR) is an important cause of morbidity. The study aim was to identify preoperative risk factors for CHF.
Methods:
A total of 500 consecutive patients (271 males, 229 females; median age 73 years; range: 71-77 years) was investigated retrospectively. The AVR was performed using a Carpentier-Edwards pericardial valve, and a total of 348 additional procedures (313 coronary artery bypass grafts; CABG) was carried out. The outcome studied was CHF, during both hospital stay and long-term follow up. Univariate and multivariate statistical analyses were used to investigate 15 risk factors.
Results:
During the hospital stay, 13 patients developed CHF, with four fatalities. Significant risk factors for CHF included urgent operation (p = 0.031), preoperative atrial fibrillation (AF) (p = 0.031) and NYHA functional class IV (p = 0.05). A logistic regression analysis revealed need for urgent operation (p = 0.034) as the sole factor. During long-term follow up, 43 patients developed CHF, with seven fatalities. Univariate analysis identified seven risk factors with significant effect: valve size <19 mm (p = 0.004), preoperative conduction defects (p = 0.007), chronic postoperative AF (p = 0.013), cross-clamp time >75 min (p = 0.032), NYHA class IV (p = 0.041), coronary artery disease (CAD) (p = 0.043) and additional CABG (p = 0.050). Multivariate analysis identified three risk factors: preoperative conduction defects (p = 0.004), postoperative AF (p = 0.005) and CAD (p = 0.037)
Conclusion:
Morbidity due to CHF after AVR could be minimized with correct treatment of AF and of conduction defects. Patient age, valve size, cross-clamp time and preoperative severity or symptoms were not independent risk factors. Moreover, small native aortic valve rings should not necessarily be enlarged, the cross-clamp time should be kept to a minimum, and surgery should not be delayed when symptoms have developed.
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction
